Patents by Inventor Kamal F. Badr

Kamal F. Badr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DETERMINATION OF RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE BY MEASURING URINARY LEVELS OF PODOCIN AND NEPHRIN MESSENGER RNA
    Publication number: 20210087634
    Abstract: A method for a determining of risk for development of cardiovascular disease by measuring levels of the at least gene of interest is disclosed. The method may identify subjects with moderate albuminuria and diagnosis or predict cardiovascular disease several years before either of these outcomes is detectable by present methodologies.
    Type: Application
    Filed: October 13, 2020
    Publication date: March 25, 2021
    Inventors: Kamal F. Badr, Assaad A. Eid, Robert H. Habib
  • Determination of risk for development of cardiovascular disease by measuring urinary levels of podocin and nephrin messenger RNA
    Patent number: 10801066
    Abstract: A method for a determining of risk for development of cardiovascular disease by measuring levels of the at least gene of interest is disclosed. The method may identify subjects with moderate albuminuria and diagnosis or predict cardiovascular disease several years before either of these outcomes is detectable by present methodologies.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: October 13, 2020
    Assignee: American University of Beirut
    Inventors: Kamal F. Badr, Assaad A Eid, Robert H. Habib
  • DETERMINATION OF RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE BY MEASURING URINARY LEVELS OF PODOCIN AND NEPHRIN MESSENGER RNA
    Publication number: 20160068911
    Abstract: A method for a determining of risk for development of cardiovascular disease by measuring levels of the at least gene of interest is disclosed. The method may identify subjects with moderate albuminuria and diagnosis or predict cardiovascular disease several years before either of these outcomes is detectable by present methodologies.
    Type: Application
    Filed: September 8, 2015
    Publication date: March 10, 2016
    Inventors: Kamal F. BADR, Assaad A. Eid, Robert H. Habib
  • Use of IL-13 to induce 15-lipoxygenase
    Patent number: 5830453
    Abstract: Methods are disclosed for inducing the production of 15-lipoxygenase (15-LO) in animal or human cells comprising monocytes via the administration of Interleukin 13 (IL-13). These methods are effective in therapy of inflammatory conditions responsive to products of 15-LO activity, including 15-s-hydroxyeicoiatetraenoic (15-S-HETE) and Lipoxin A.sub.4 (LXA.sub.4). Such administration directs intervention to specific and effectors of inflammation, rather than the current methods of symptomatic treatment.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: November 3, 1998
    Assignee: Emory University
    Inventors: Kamal F. Badr, Fadi G. Lakkis